Pune, India

Mukund Keshav Gurjar

This inventor holds 29 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Emcure Pharmaceuticals Limited, Council of Scientific and Industrial Research, Dabur Research Foundation. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukund Keshav Gurjar. Retrieved from https://idiyas.com/inventor/mukund-keshav-gurjar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 

% Patents Active = 37.9

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Maharashtra, IN (2004 - 2018)
  • Pune, IN (2003 - 2020)
  • Bhosari, IN (2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Carmustine
Stable Formulation
Isoproterenol Hydrochloride
Lipid Formulations
Prostacyclin Derivatives
Controlled Release
Raltegravir
Taxane Derivatives
Fingolimod Hydrochloride
Chiral Amlodipine
Cancer Therapy
Optically Active Compounds
29 patents (USPTO):Explore Patents

Sure, I can help you with that. Let's start with an article about inventor Mukund Keshav Gurjar.

Title: Mukund Keshav Gurjar - Innovating the Pharmaceutical Industry

Introduction: Mukund Keshav Gurjar is a prolific inventor based in Pune, India, with a remarkable track record in the field of pharmaceuticals. With 28 patents to his name, Gurjar continues to drive innovation in the industry with his groundbreaking inventions.

Latest Patents: Among his latest patents is the "Stable ready-to-use carmustine pharmaceutical composition," a revolutionary solution that eliminates the need for prior dissolution or dilution of carmustine before adding it to parenteral solutions. Additionally, Gurjar's "Process for preparation of isoproterenol hydrochloride" showcases his expertise in developing efficient processes for pharmaceutical synthesis.

Career Highlights: Gurjar has made significant contributions to companies such as Emcure Pharmaceuticals Limited and the Council of Scientific & Industrial Research. His innovative spirit and dedication to advancing pharmaceutical technologies have garnered him recognition in the industry.

Collaborations: Throughout his career, Gurjar has collaborated with esteemed professionals in the field, including coworkers such as Samit Satish Mehta and Ramesh Anna Joshi. These collaborations have led to the development of cutting-edge solutions that address critical needs in the pharmaceutical sector.

Conclusion: Mukund Keshav Gurjar stands as a beacon of innovation in the pharmaceutical industry, with a portfolio of patents that reflect his commitment to pushing boundaries and improving patient care. His contributions continue to inspire and shape the future of pharmaceutical research and development.

I hope this article captures the essence of Mukund Keshav Gurjar's impressive career and contributions to the world of pharmaceutical innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…